Format

Send to

Choose Destination
Lancet Infect Dis. 2001 Oct;1(3):199-202.

Multidrug-resistant tuberculosis--can the tide be turned?

Author information

1
Centre for Infectious Diseases and International Health, Royal Free and University College Medical School, Windeyer Institute for Medical Science, London, UK. a.zumla@ucl.ac.uk

Abstract

Despite continued control efforts, tuberculosis remains a leading cause of illness and death worldwide, with more cases today than at any previous time in history. Not only is there a global increase in the disease itself, there is a worrying rise in the number of cases resistant to the two principal antituberculosis drugs, isoniazid and rifampicin--so called multidrug resistance.

PMID:
11871496
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center